SEER is an authoritative source of information on cancer incidence and survival in the United States. SEER currently collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 28 percent of the U.S. population.
Code grade specified by pathologist. If no grade specified, code 9
See abstractor notes
This is an AML generally showing maturation in the megakaryocytelineage. This occurs most commonly in infants without Downs Syndrome with a female predominance. This disease is restricted to infants and young children with most cases occurring in the first 6 months of life.